Remdesivir is an overpriced, sometimes harmful and mostly ineffective patented medication being promoted by liberals to treat coronavirus. It is administered intravenously and thus requires a very costly 5-day stay in a hospital, in addition to thousands of dollars per patient charged by a pharmaceutical company for the medication itself. Although remdesivir was heavily touted by liberals, on Oct. 16 CNN admitted, "Big global study finds remdesivir doesn't help Covid-19 patients."
As of November 19, 2020, "A World Health Organization panel is now recommending against the use of the antiviral remdesivir in hospitalized Covid-19 patients, saying there is no evidence that the drug — which U.S. regulators have approved for the treatment of the coronavirus — improves mortality."
Remdesivir depends on a very specific enzyme and thus might not work if its conformation is slightly changed. The overall costs, including hospital expenses, for administering remdesivir to a patient can be as high as $20,000 for a full treatment. But hospitals receive special financial incentives to administer remdesivir despite its ineffectiveness.
Some suspect that overuse of remdesivir may result in viral resistance to the drug, which is a strong reason to prefer hydroxychloroquine over remdesivir.
- "CMS in October announced interim add-on payments for COVID-19 treatments including remdesivir through the HHS-declared public health emergency. The declaration next expires in January, though stakeholders think it’s likely the emergency will be renewed."